GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Paion Ag (OTCPK:PAIOF) » Definitions » EV-to-Revenue

Paion Ag (Paion Ag) EV-to-Revenue : 1.14 (As of Apr. 29, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Paion Ag EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Paion Ag's enterprise value is $18.05 Mil. Paion Ag's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $15.85 Mil. Therefore, Paion Ag's EV-to-Revenue for today is 1.14.

The historical rank and industry rank for Paion Ag's EV-to-Revenue or its related term are showing as below:

PAIOF' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.26   Med: 14.69   Max: 1532.46
Current: 1.14

During the past 13 years, the highest EV-to-Revenue of Paion Ag was 1532.46. The lowest was -0.26. And the median was 14.69.

PAIOF's EV-to-Revenue is ranked better than
76.46% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.295 vs PAIOF: 1.14

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-29), Paion Ag's stock price is $0.0251. Paion Ag's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $2.22. Therefore, Paion Ag's PS Ratio for today is 0.01.


Paion Ag EV-to-Revenue Historical Data

The historical data trend for Paion Ag's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paion Ag EV-to-Revenue Chart

Paion Ag Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.63 14.51 7.19 14.06 1.22

Paion Ag Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.36 14.06 17.64 1.22 12.99

Competitive Comparison of Paion Ag's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Paion Ag's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paion Ag's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Paion Ag's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Paion Ag's EV-to-Revenue falls into.



Paion Ag EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Paion Ag's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=18.053/15.85
=1.14

Paion Ag's current Enterprise Value is $18.05 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Paion Ag's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $15.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paion Ag  (OTCPK:PAIOF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Paion Ag's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0251/2.223
=0.01

Paion Ag's share price for today is $0.0251.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was $2.22.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paion Ag EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Paion Ag's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Paion Ag (Paion Ag) Business Description

Traded in Other Exchanges
Address
Heussstrasse 25, Aachen, DEU, 52078
Paion Ag is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.